Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, announced a strategic collaboration agreement with Takeda to use its proprietary end-to-end platform,...
Fresh off its landmark December 2025 listing on the Hong Kong Stock Exchange, Insilico Medicine has inked a multi-year R&D collaboration with global pharma...